Friday, July 24, 2020

Cipla Gets Regulatory Nod To Sell COVID-19 Drug

Cipla said it would launch favipiravir as "Ciplenza" in the first week of August, priced at Rs 68 (91 cents) per 200 mg tablet.

from NDTV Profit - Latest https://ift.tt/3fUzrIi
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)